Dr. Joel Picus
Claim this profileWashington University School of Medicine
Studies Prostate Cancer
Studies Renal Cell Carcinoma
12 reported clinical trials
30 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Renal Cell Carcinoma
Stage IV
Stage III
TFE-3/B translocation positive
Affiliated Hospitals
Clinical Trials Joel Picus is currently running
Personalized Cancer Vaccine
for Bladder Cancer
This is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors and molecular residual disease. The hypothesis of the trial is that synthetic long peptide personalized cancer vaccines will be safe and capable of generating measurable neoantigen-specific T-cell responses enabling ctDNA clearance. The personalized cancer vaccines are composed of synthetic long peptides corresponding to prioritized cancer neoantigens and will be co-administered with poly-ICLC.
Recruiting1 award Phase 17 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
More about Joel Picus
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Joel Picus has experience with
- Prednisone
- Abiraterone Acetate
- Nivolumab
- Lenvatinib
- Pembrolizumab
- Research Blood Collection
Breakdown of trials Joel Picus has run
Prostate Cancer
Renal Cell Carcinoma
Kidney Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joel Picus specialize in?
Joel Picus focuses on Prostate Cancer and Renal Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Joel Picus currently recruiting for clinical trials?
Yes, Joel Picus is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Joel Picus has studied deeply?
Yes, Joel Picus has studied treatments such as Prednisone, Abiraterone Acetate, Nivolumab.
What is the best way to schedule an appointment with Joel Picus?
Apply for one of the trials that Joel Picus is conducting.
What is the office address of Joel Picus?
The office of Joel Picus is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.